Natural Alternatives International Inc income statement

In fiscal 2026, Natural Alternatives International Inc reported revenue of $143m, up 9.7% on the year before, operating income of −$18.8m (a -13.2% margin) and net income of −$20.7m, or −$3.43 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Natural Alternatives International Inc: income statement, annual
Fiscal year	2011Jun 2011	2012Jun 2012	2013Jun 2013	2014Jun 2014	2015Jun 2015	2016Jun 2016	2017Jun 2017	2018Jun 2018	2019Jun 2019	2020Jun 2020	2021Jun 2021	2022Jun 2022	2023Jun 2023	2024Jun 2024	2025Jun 2025	2026Jun 2026
Revenue	56	73	63	74	80	114	122	132	138	119	179	171	154	114	130	143
Cost of revenue	—	—	—	—	—	—	96	106	115	100	148	140	136	107	121	134
Gross profit	11	15	12	13	14	25	26	26	24	19	30	31	18	7	9	9
Research and development	1	1	1	1	1	1	2	2	2	2	2	3	2	2	2	2
Selling, general and administrative	8	9	10	10	10	13	17	17	18	17	—	—	—	—	—	—
Operating income	2	6	2	3	4	12	10	10	6	−2	14	14	5	−9	−9	−19
Interest expense	0	0	0	0	0	—	—	—	—	—	—	—	—	—	—	—
Net interest income	—	—	—	—	−0	0	−0	−0	−0	−0	−0	−0	−0	−0	−1	−1
Income before tax	2	6	2	3	4	14	10	11	8	−2	12	14	4	−9	−11	−20
Income tax	−3	2	1	1	1	4	3	6	1	−0	1	3	1	−2	3	0
Net income	5	4	2	2	3	10	7	5	7	−2	11	11	3	−7	−14	−21
Diluted EPS	$0.71	$0.59	$0.23	$0.29	$0.49	$1.44	$1.09	$0.73	$0.92	−$0.25	$1.69	$1.74	$0.43	−$1.23	−$2.28	−$3.43
Diluted shares (average)	7m	7m	7m	7m	7m	7m	7m	7m	7m	7m	6m	6m	6m	6m	6m	6m
EBITDA	6	9	5	6	7	14	12	12	9	2	18	18	9	−4	−4	−14

US$ millions unless shown otherwise. Fiscal quarters.

Natural Alternatives International Inc: income statement, quarterly
Quarter	2025 Q1Sept 2024	2025 Q2Dec 2024	2025 Q3Mar 2025	2025 Q4Jun 2025	2026 Q1Sept 2025	2026 Q2Dec 2025	2026 Q3Mar 2026	2026 Q4Jun 2026
Revenue	33	34	29	34	38	35	35	35
Cost of revenue	31	32	27	30	33	32	35	33
Gross profit	2	2	2	4	4	2	0	2
Selling, general and administrative	4	4	4	—	4	4	4	—
Operating income	−2	−3	−2	−2	0	−2	−4	−13
Net interest income	−0	−0	−0	−0	−0	−0	−0	−0
Income before tax	−2	−3	−3	−3	−0	−2	−4	−13
Income tax	−0	−1	−0	4	0	0	0	0
Net income	−2	−2	−2	−7	−0	−3	−4	−14
Diluted EPS	−$0.33	−$0.37	−$0.37	−$1.21	−$0.05	−$0.42	−$0.72	−$2.24
EBITDA	−1	−2	−1	−1	1	−1	−3	−12

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: NAII vs ZVRA HRTX vs NAII NAGE vs NAII

More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies

Figures from Natural Alternatives International Inc's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Natural Alternatives International Inc.